Boston-Area Tech Layoffs Slow: A Recap of Summer’s Job Cuts at Analog Devices, CombinatoRx, and Other Firms
Ryan McBride8/17/09Comments (2)
(Page 3 of 3)
180 jobs, including its entire 150-person sales force. About a month later the company, which makes a drug to treat high cholesterol and an antibiotic, filed for Chapter 11 bankruptcy. Here’s our report on that unfortunate development.
—I also had the bitter-sweet experience of breaking the news in June about 60 Indevus Pharmaceuticals workers who were laid off or expected to be let go as a result of the acquisition of the Lexington, MA, drug developer by Endo Pharmaceuticals (NASDAQ:ENDP), of Chadds Ford, PA. The laid-off workers represented about a quarter of the 240 employees at Indevus when Endo completed its $370 million buyout of the firm in March, a company spokesman told me.
andrew kolodziej
8/17/09 1:51 pm
You could add to the list EPIX Pharmaceuticals which ceased operations in July, letting go their remaining ~30-40 workers (on the heals of a March layoff of about the same size).
Recruiter Bill
11/2/09 7:50 pm
Chatter I hear has improved somewhat over the past 2 months. In my business there is talk of a little uptick in hiring albeit early next year.